News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
206,653 Results
Type
Article (34497)
Company Profile (41)
Press Release (172115)
Section
Business (59682)
Career Advice (432)
Deals (5337)
Drug Delivery (13)
Drug Development (27180)
Employer Resources (50)
FDA (3830)
Job Trends (3912)
News (94051)
Policy (5256)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Pharm Country Standard (2)
2026 Biotech Bay Standard (1)
Academia (2425)
Academic (1)
Accelerated approval (1)
Adcomms (7)
Allergies (21)
Alliances (12819)
ALS (27)
Alzheimer's disease (592)
Antibody-drug conjugate (ADC) (26)
Approvals (3850)
Artificial intelligence (67)
Autoimmune disease (2)
Automation (7)
Bankruptcy (37)
Best Places to Work (3066)
BIOSECURE Act (5)
Biosimilars (9)
Biotechnology (34)
Bladder cancer (20)
Brain cancer (7)
Breast cancer (91)
Cancer (647)
Cardiovascular disease (44)
Career advice (392)
Career pathing (9)
CAR-T (45)
Cell therapy (125)
Cervical cancer (7)
Clinical research (21050)
Collaboration (200)
Compensation (45)
Complete response letters (1)
COVID-19 (1233)
CRISPR (19)
C-suite (142)
Cystic fibrosis (40)
Data (765)
Decentralized trials (1)
Denatured (3)
Depression (8)
Diabetes (56)
Diagnostics (1851)
Digital health (2)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (23)
Drug pricing (10)
Drug shortages (1)
Duchenne muscular dystrophy (24)
Earnings (9113)
Editorial (4)
Employer branding (8)
Employer resources (42)
Events (28948)
Executive appointments (439)
FDA (4092)
Featured Employer (7)
Frontotemporal dementia (4)
Funding (232)
Gene editing (43)
Generative AI (3)
Gene therapy (87)
GLP-1 (158)
Government (1034)
Guidances (6)
Healthcare (5982)
Huntington's disease (3)
IgA nephropathy (6)
Immunology and inflammation (18)
Indications (9)
Infectious disease (1263)
Inflammatory bowel disease (44)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (17)
Interviews (53)
IPO (2626)
IRA (6)
Job creations (938)
Job search strategy (365)
Kidney cancer (5)
Labor market (8)
Layoffs (77)
Leadership (2)
Legal (1130)
Liver cancer (19)
Lung cancer (89)
Lymphoma (41)
Machine learning (1)
Management (12)
Manufacturing (51)
MASH (27)
Medical device (3613)
Medtech (3614)
Mergers & acquisitions (2816)
Metabolic disorders (136)
Multiple sclerosis (20)
NASH (5)
Neurodegenerative disease (24)
Neuropsychiatric disorders (3)
Neuroscience (733)
NextGen: Class of 2025 (2085)
Non-profit (1864)
Northern California (697)
Now hiring (10)
Obesity (55)
Opinion (33)
Ovarian cancer (38)
Pain (14)
Pancreatic cancer (26)
Parkinson's disease (41)
Partnered (4)
Patents (39)
Patient recruitment (30)
Peanut (13)
People (34125)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase I (6788)
Phase II (9640)
Phase III (6364)
Pipeline (233)
Podcasts (5)
Policy (21)
Postmarket research (1060)
Preclinical (3574)
Press Release (27)
Prostate cancer (27)
Psychedelics (9)
Radiopharmaceuticals (102)
Rare diseases (115)
Real estate (1797)
Recruiting (24)
Regulatory (3561)
Reports (5)
Research institute (1413)
Resumes & cover letters (34)
Rett syndrome (1)
RNA editing (1)
RSV (1)
Schizophrenia (13)
Series A (42)
Series B (24)
Service/supplier (1)
Sickle cell disease (21)
Southern California (563)
Spinal muscular atrophy (43)
Sponsored (7)
Startups (1427)
Stomach cancer (2)
Supply chain (3)
The Weekly (2)
United States (6338)
Vaccines (216)
Venture capitalists (3)
Webinars (9)
Weight loss (27)
Women's health (6)
Worklife (3)
Date
Today (56)
Last 7 days (201)
Last 30 days (763)
Last 365 days (9384)
2025 (2231)
2024 (9802)
2023 (12099)
2022 (14820)
2021 (16113)
2020 (15233)
2019 (14543)
2018 (10784)
2017 (10185)
2016 (10546)
2015 (12358)
2014 (9322)
2013 (8900)
2012 (8991)
2011 (8855)
2010 (7942)
Location
Africa (285)
Alabama (16)
Alaska (3)
Arizona (40)
Arkansas (7)
Asia (11601)
Australia (2836)
California (1475)
Canada (471)
China (115)
Colorado (60)
Connecticut (69)
Delaware (31)
Europe (31598)
Florida (168)
Georgia (56)
Idaho (12)
Illinois (127)
India (3)
Indiana (66)
Iowa (3)
Japan (49)
Kansas (13)
Kentucky (4)
Maine (13)
Maryland (152)
Massachusetts (2164)
Michigan (43)
Minnesota (78)
Mississippi (1)
Missouri (22)
Montana (10)
Nebraska (4)
Nevada (12)
New Hampshire (10)
New Jersey (388)
New Mexico (9)
New York (419)
North Carolina (275)
North Dakota (2)
Northern California (697)
Ohio (69)
Oklahoma (7)
Oregon (10)
Pennsylvania (282)
Puerto Rico (2)
Rhode Island (8)
South America (327)
South Carolina (3)
Southern California (563)
Tennessee (24)
Texas (192)
Utah (42)
Virginia (32)
Washington D.C. (17)
Washington State (145)
West Virginia (1)
Wisconsin (9)
206,653 Results for "boston university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boston Scientific announces conference call discussing first quarter 2025 results
April 1, 2025
·
1 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Gene therapy
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
August 14, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Boston Scientific announces pricing of €1.5 billion of senior notes
February 24, 2025
·
5 min read
Press Releases
Boston Scientific announces completion of €1.5 billion offering of senior notes
February 27, 2025
·
4 min read
Press Releases
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
March 7, 2025
·
6 min read
Business
Novo Holdings Boston office named a 2024 Best Place to Work by the Boston Business Journal
Novo Holdings, a leading life science investor, announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business Journal.
May 23, 2024
·
2 min read
Press Releases
Boston Scientific to participate in TD Cowen’s 45th Annual Health Care Conference
February 19, 2025
·
1 min read
Press Releases
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
February 25, 2025
·
1 min read
1 of 20,666
Next
